Bio-succinic acid capacity continues to grow: Update on Succinity, Reverdia, and Novomer

BASF and Purac (CSM)'s 50-50 joint venture (see the August 11, 2011 LRMCJ), now named Succinity, expects its first plant – a 10,000-metric-ton facility – to be operational in late 2013. This is on track with the with the target announced last year. Succinity is currently modifying a fermentation fac...

This research is archived and therefore no longer available. For further assistance please contact your Customer Success Manager or email ClientEngagementTeam@luxresearchinc.com. Thank you!

Related Research

Braskem and Haldor Topsoe achieve demo-scale production of bio-MEG

News Commentary | November 25, 2020

While it is promising that Braskem and Haldor Topsoe are on track to achieving their commercial‑scale facility in 2023, they aren't the only players vying for a lower‑cost route to bio‑MEG. UPM's biorefinery is still on schedule to be complete at the end of 2022. Braskem and Haldor's two‑step bio‑... Not part of subscription

EnginZyme extends its Series A to €11 million

News Commentary | February 26, 2021

The funds will allow the company to further demonstrate the scalability of cell‑free production platforms. EnginZyme claims it has already produced catalysts at multi‑kg scales and operated pilots capable of producing 50 tons per year of product. While this is an impressive milestone, the company ... Not part of subscription

LCY Biosciences putting BioAmber's assets to use in Sarnia and planning to ramp up operations

News Commentary | August 30, 2021

This announcement is the first piece of positive news for the succinic acid space in years. In late 2018, LCY acquired the Sarnia plant and said it would continue BioAmber's legacy and produce succinic acid, at least in the short run. Today, the company is producing 18,000 metric tons of succinic ... Not part of subscription